Express Pharma

Panel Discussion on ‘Bridging gaps in disease management’ | FDD Conclave 2022

1 199


Panelists in this video:
+ Dr Ashok Omray, Pharma Consultant
+ Dr Sukhjeet Singh, Chief Scientific Officer, Sentiss Pharma
+ Dr Subhrangshu Sengupta, VP, R&D – Formulation, IPCA Laboratories
+ Dr Pirthipal Singh, VP & Head – R&D, Tirupati Group
+ Dr Sandhya Shenoy, AVP-R&D, FDC
+ Dr Rahul Dabre, VP and Head-Formulation, Alembic Research Centre

Moderator:
+ Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare, The Indian Express Group

Key Highlights:
+ Pandemic was a tough teacher but it enabled us to identify and bridge crucial gaps in disease management, beyond COVID as well: Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare, The Indian Express Group

+ Disease management and health management is a global requirement: Dr Ashok Omray, Pharma Consultant

+ In the post-COVID era, regulation and standardisation of products is the need of the hour: Dr Sukhjeet Singh, Chief Scientific Officer, Sentiss Pharma

+ Beyond COVID, pharma and nutra need to work together to bridge the gap in disease management: Dr Subhrangshu Sengupta, VP, R&D – Formulation, IPCA Laboratories

+ Evidence based nutraceutical is the need of the hour: Dr Pirthipal Singh, VP & Head – R&D, Tirupati Group

+ Collaboration is crucial in bridging the gaps in disease management: Dr Sandhya Shenoy, AVP-R&D, FDC

+ Better disease management is achieved through patient compliance and FRD scientists are playing a bigger role in this area: Dr Rahul Dabre, VP and Head-Formulation, Alembic Research Centre

- Advertisement -